A. Virkamaki et H. Ykijarvinen, ROLE OF PROSTAGLANDINS IN MEDIATING ALTERATIONS IN GLUCOSE-METABOLISMDURING ACUTE ENDOTOXEMIA IN THE RAT, Endocrinology, 136(4), 1995, pp. 1701-1706
We determined the role of prostanoids in mediating alterations in gluc
ose metabolism during lipopolysaccharide (LPS)-induced (1 mg/ kg, LD(1
0)) acute endotoxemia in chronically catheterized awake rats. Basal gl
ucose turnover (R(t), infusion of[5-H-3]glucose), in vivo insulin acti
on on overall glucose utilization under normoglycemic conditions (eugl
ycemic clamp), whole body glycolysis, and muscle glycogen synthesis we
re determined in four groups of rats. These groups received 1) LPS (LP
S rats, n = 6); 2) saline (control rats, n = 6); 3) indomethacin and L
PS (INDO and LPS rats, n = 6); or 4) saline and indomethacin (INDO con
trol rats, n = 6). In the fasted rats, LPS induced hyperthermia, hypot
ension, and hyperglycemia. These changes were associated with glycogen
depletion in both skeletal muscle and liver and with increased R(t).
During hyperinsulinemia, whole body glucose disposal was decreased by
37% due to decreased muscle glycogen synthesis and glycogen synthase a
ctivity whereas the rate of whole body glycolysis was normal. INDO abo
lished hyperthermia, hypotension, and hyperglycemia but did not improv
e whole body insulin sensitivity, muscle glycogen synthesis, or glycog
en synthase activity. These data indicate that prostanoids mediate hyp
otension, transient fasting hyperglycemia, and fever during LPS-induce
d acute endotoxemia. They do not, however, explain insulin resistance
under these conditions.